Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Doriguzzi Breatta E"'
Autor:
Quotti Tubi L; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Canovas Nunes S; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Mandato E; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pizzi M; Department of Medicine, Cytopathology and Surgical Pathology Unit, University of Padova, Italy., Vitulo N; Department of Biotechnology, University of Verona, Italy., D'Agnolo M; Department of Women's and Child's Health, University of Padova, Italy., Colombatti R; Department of Women's and Child's Health, University of Padova, Italy., Martella M; Department of Women's and Child's Health, University of Padova, Italy., Boaro MP; Department of Women's and Child's Health, University of Padova, Italy., Doriguzzi Breatta E; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Fregnani A; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Spinello Z; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Nabergoj M; Hematology Service, Institut Central des Hôpitaux (ICH), Hôpital du Valais, Sion, Switzerland., Filhol O; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1036, Institute de Reserches en Technologies et Sciences pour le Vivant/Biologie du Cancer et de l'Infection, Grenoble, France., Boldyreff B; Kinase Detect, Krusaa, Denmark., Albiero M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy.; Veneto Institute of Molecular Medicine, Experimental Diabetology Lab, Padova, Italy., Fadini GP; Veneto Institute of Molecular Medicine, Experimental Diabetology Lab, Padova, Italy.; Department of Medicine, University of Padova, Italy., Gurrieri C; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Vianello F; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Semenzato G; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Manni S; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Trentin L; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Piazza F; Department of Medicine, Division of Hematology, University of Padova, Italy.; Laboratory of Normal and Malignant Hematopoiesis and Pathobiology of Myeloma and Lymphoma. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.
Publikováno v:
HemaSphere [Hemasphere] 2023 Nov 23; Vol. 7 (12), pp. e978. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).
Autor:
Quotti Tubi, L, Canovas Nunes, S, Brancalion, A, Doriguzzi Breatta, E, Manni, S, Mandato, E, Zaffino, F, Macaccaro, P, Carrino, M, Gianesin, K, Trentin, L, Binotto, G, Zambello, R, Semenzato, G, Gurrieri, C, Piazza, F
Publikováno v:
Leukemia; February 2017, Vol. 31 Issue: 2 p292-300, 9p
Autor:
Bruserud, Øystein1,2 (AUTHOR) hakon.reikvam@uib.no, Reikvam, Håkon1,2 (AUTHOR)
Publikováno v:
Cancers. Jul2023, Vol. 15 Issue 14, p3711. 21p.
Autor:
Vázquez-Blomquist, Dania1 (AUTHOR) dania.vazquez@cigb.edu.cu, Ramón, Ailyn C.2 (AUTHOR), Rosales, Mauro2,3 (AUTHOR), Pérez, George V.2 (AUTHOR), Rosales, Ailenis3 (AUTHOR), Palenzuela, Daniel1 (AUTHOR), Perera, Yasser2,4 (AUTHOR) ypereranegrin@ccbjic.com, Perea, Silvio E.2 (AUTHOR) silvio.perea@cigb.edu.cu
Publikováno v:
BMC Genomics. 7/4/2023, Vol. 24 Issue 1, p1-16. 16p.
Autor:
Chen, Xiu-min1,2,3,4 (AUTHOR), Gao, Kai-xin2,5 (AUTHOR), Wu, Xiao-Dong2,5 (AUTHOR), Liang, Huang-sheng5 (AUTHOR), Liu, Ze-hao5 (AUTHOR), Wang, Mao-jie2,4 (AUTHOR), Mei, Li-yan2 (AUTHOR), Huang, Qing-chun1,2,3,4 (AUTHOR), Huang, Run-yue1,2,4 (AUTHOR)
Publikováno v:
Journal of Immunology Research. 7/4/2022, p1-13. 13p. 1 Chart, 6 Graphs.
Autor:
Ha TQ; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Erikstein BS; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway., Popa M; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; KinN Therapeutics AS, Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Reikvam H; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Leukemia Research Group, Department of Clinical Science, University of Bergen, Bergen, Norway., McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Nov 24. Date of Electronic Publication: 2024 Nov 24.
Autor:
Deng H; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Rao X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhang S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Chen L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zong Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhou R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Meng R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wu G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Li Q; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Publikováno v:
BioFactors (Oxford, England) [Biofactors] 2024 Jul-Aug; Vol. 50 (4), pp. 624-633. Date of Electronic Publication: 2023 Dec 29.
Autor:
Richter, Anna1 (AUTHOR), Sender, Sina1 (AUTHOR), Lenz, Annemarie1 (AUTHOR), Schwarz, Rico2 (AUTHOR), Hinz, Burkhard2 (AUTHOR), Knuebel, Gudrun1 (AUTHOR), Sekora, Anett1 (AUTHOR), Murua Escobar, Hugo1 (AUTHOR), Junghanss, Christian1 (AUTHOR) Christian.junghanss@med.uni-rostock.de, Roolf, Catrin1 (AUTHOR)
Publikováno v:
BMC Cancer. 3/4/2020, Vol. 20 Issue 1, p1-10. 10p. 3 Graphs.
Autor:
Trembley, Janeen H., Kren, Betsy T., Afzal, Muhammad, Scaria, George A., Klein, Mark A., Ahmed, Khalil
Publikováno v:
Molecular & Cellular Biochemistry; Apr2023, Vol. 478 Issue 4, p899-926, 28p
Autor:
Xue, Cuiling1 (AUTHOR), Zhang, Jialing2 (AUTHOR), Zhang, Guiju3 (AUTHOR), Xue, Yuyan4 (AUTHOR), Zhang, Guiyan5 (AUTHOR), Wu, Xia2 (AUTHOR) wuxia42561956@163.com
Publikováno v:
Oncology Letters. Sep2019, Vol. 18 Issue 3, p2877-2884. 8p.